[Paradoxal lowering of parasympathetic indices in myasthenic patients].
Myasthenia gravis is an autoimmune disease presenting antibodies developed against the nicotinic receptors of acetylcholine. The aim of this study was to evaluate heart rate variability in these patients. Heart rate variability was studied with 24 hour Holter recordings. Eighteen myasthenic patients, 7 men and 11 women, under pyridostigmine treatment, with an average age of 40 years (25 to 63 years) were aged and gender matched to a control group of 18 healthy subjects. All patients exhibited normal cardiac status and Doppler echocardiography. The following parameters were collected over 24 hours and the data further differentiated between night and day: for the temporal domain: heart rate, SDNN, pNN50, rMSSD; and for the spectral domain: total power, high frequency (HF) and low frequency (LF) power. The mean heart rate was slightly higher in the myasthenic group (non significant), due to a less marked nocturnal bradycardia. There was a decrease in the observed absolute values of SDNN as well as temporal and spectral parasympathetic indices (pNN50, rMSSD, HF) (p < 0.01) over the 24 hour period. The results were more significant during the night. Cardiac parasympathetic modulation is significantly modified in myasthenic patients. Considering that lack of bradycardia argues against an over active vagal tone, three hypothesis are discussed that favor of a low vagal tone: antibodies effects on the nicotinic receptors of the autonomic nervous system, respiratory impairment and a desensitization of the acetylcholine receptors.
Service de cardiologie, syndicat interhospitalier de la communauté urbaine de Strasbourg, Schiltigeim.
M P
MP
Douchet
E
E
Quiring
F
F
Bronner
R
R
Vi-Fane
M
M
Messier
M
M
Chauvin
J M
JM
Warter
D000328:Adult; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000503:physiopathology*; D010275:Parasympathetic Nervous System / Q000503:physiopathology
Diminution paradoxale des paramètres parasympathiques chez les patients myasthéniques.